Related Experiment Video
Updated: Apr 11, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Toll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis
Trudy McGarry1, Douglas J Veale2, Wei Gao3
1Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin Academic Health Care and The Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland. trudy.mc-garry@ucdconnect.ie.
Introduction:
This study investigates the role of Toll-like receptor 2 (TLR2) in the regulation of migratory and invasive mechanisms in rheumatoid arthritis (RA).
Methods:
Invasion, migration, matrix metalloproteinase (MMP)-1, -3 and tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) expression, β-integrin binding, cytoskeletal rearrangement and Ras-related C3 botulinum toxin substrate 1 (Rac1) activation in response to a TLR2-ligand, Pam3CSK4 (1 μg/ml), in ex vivo RA synovial tissue explants, primary RA synovial fibroblasts (RASFC) and microvascular endothelial cells (HMVEC) were assessed by Transwell Matrigel™ invasion chambers, enzyme-linked immunosorbent assay (ELISA), multiplex adhesion binding assay, reverse transcription polymerase chain reaction (RT-PCR), F-actin immunofluorescent staining, matrigel synovial outgrowths, Rac1 pull-down assays/Western blot and zymography. β1-integrin expression in RA/control synovial tissue was assessed by immunohistology. The effect of Pam3CSK4 on cell migration, invasion, MMP-3 and Rac1 activation was examined in the presence or absence of anti-β1-integrin (10 μg/ml) or anti-IgG control (10 μg/ml). The effect of an anti-TLR-2 mAb (OPN301)(1 μg/ml) or immunoglobulin G (IgG) control (1 μg/ml) on RASFC migration and RA synovial tissue MMP activity was assessed by wound assays, ELISA and zymography.
Results:
Pam3CSK4 significantly induced cell migration, invasion, MMP-1, MMP-3, MMP-2 and MMP-9 expression and induced the MMP-1/TIMP-3 and MMP-3/TIMP-3 ratio in RASFC and explants (p <0.05). β1-integrin expression was significantly higher in RA synovial tissue compared to controls (p <0.05). Pam3CSK4 specifically induced β1-integrin binding in RASFC (p <0.05), with no effect observed for β2-4, β6, αvβ5 or α5β1. Pam3CSK4 increased β1-integrin mRNA expression, Rac1 activation, RASFC outgrowths and altered cytoskeletal dynamic through induction of filopodia formation. Pam3CSK4-regulated cell migration and invasion processes, but not MMP-3, were inhibited in the presence of anti-β1-integrin (p <0.05), with no effect observed for anti-IgG control. Furthermore, anti-β1-integrin inhibited Pam3CSK4-induced Rac1 activation. Finally, blockade of TLR2 with OPN301 significantly decreased spontaneous release of MMP-3, MMP-2 and MMP-9 and increased TIMP-3 secretion from RA synovial explant cultures (p <0.05). Incubation of RASFC with OPN301 RA ex vivo conditioned media inhibited migration and invasion compared to IgG control.
Conclusions:
TLR2 activation induces migrational and invasive mechanisms, which are critically involved in the pathogenesis of RA, suggesting TLR2 as a potential therapeutic target for the treatment of RA.
Insights
Toll-like receptor 2 (TLR2) activation promotes rheumatoid arthritis (RA) cell migration and invasion. Blocking TLR2 or β1-integrin can inhibit these RA pathogenesis mechanisms, suggesting TLR2 as a therapeutic target.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Rheumatoid arthritis (RA) pathogenesis involves complex cellular mechanisms.
- Toll-like receptor 2 (TLR2) plays a role in inflammatory responses.
Purpose of the Study:
- To investigate the role of TLR2 in regulating migratory and invasive mechanisms in rheumatoid arthritis (RA).
Main Methods:
- Assessed cell migration, invasion, matrix metalloproteinase (MMP) expression, and β-integrin binding in RA synovial tissue explants and cells.
- Utilized TLR2 ligand (Pam3CSK4) and antibodies for TLR2 and β1-integrin blockade.
- Employed techniques including Transwell assays, ELISA, RT-PCR, Western blot, and zymography.
Main Results:
- TLR2 activation by Pam3CSK4 significantly increased cell migration, invasion, and MMP expression in RA models.
- β1-integrin expression was elevated in RA tissue and critical for Pam3CSK4-induced migration and invasion.
- Blocking TLR2 or β1-integrin inhibited key RA pathogenic mechanisms.
Conclusions:
- TLR2 activation drives critical migratory and invasive processes in RA pathogenesis.
- Targeting TLR2 presents a potential therapeutic strategy for RA treatment.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Cell Migration
Cell Polarization by Rho Proteins
MAPK Signaling Cascades

